Remegen Co. Ltd. Class ASSE: 688331

Indicative Announcement on Obtaining Term Compensation for Core Drug Patent

· Issued by Remegen Co. Ltd. Class A via Shanghai Stock Exchange
Indicative Announcement on Obtaining Term Compensation for Core Drug Patent

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment